Leube and Mühlbauer et al. adoptively transferred either 100 unlabeled OT-I cells or up to 8 single, trackable OT-I cells into mice, then exposed them to Listeria monocytogenes expressing either the SIINFEKL peptide (high affinity) or altered peptide ligands (medium or low affinity). Using single-cell in vivo fate mapping and high throughput flow cytometric enrichment, they found that a majority of high-affinity, but only a small portion of available low-affinity antigen-specific T cells were recruited, with the rest ignoring the priming antigen and persisting in a naive state, remaining fully responsive to subsequent challenge with a high-affinity ligand.

Contributed by Lauren Hitchings

ABSTRACT: T cell ignorance is a specific form of immunological tolerance. It describes the maintenance of naivety in antigen-specific T cells in vivo despite the presence of their target antigen. It is thought to mainly play a role during the steady state, when self-antigens are presented in absence of costimulatory signals and at low density or to T cells of low affinity. In how far antigen-specific T cells can also remain clonally ignorant to foreign antigens, presented in the inflammatory context of systemic infection, remains unclear. Using single-cell in vivo fate mapping and high throughput flow cytometric enrichment, we find that high-affinity antigen- specific CD8(+) T cells are efficiently recruited upon systemic infection. In contrast, most low- affinity antigen-specific T cells ignore the priming antigen and persist in the nave state while remaining fully responsive to subsequent immunization with a high-affinity ligand. These data establish the widespread clonal ignorance of low-affinity T cells as a major factor shaping the composition of antigen-specific CD8(+) T cell responses to systemic infection. This article is protected by copyright. All rights reserved.

Author Info: (1) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (2) Institute for Medical Microbiology, Immunology and Hygien

Author Info: (1) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (2) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (3) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (4) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (5) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. German Center for Infection Research (DZIF), Partner site Munich, Germany. (6) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. (7) Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.